Diagnostic workup of acute leukemias of ambiguous lineage.
Patel SS, Weinberg OK.
Am J Hematol. 2020 Jun;95(6):718-722. doi: 10.1002/ajh.25771. Epub 2020 Mar 19.
PMID:32124470
Acute leukemia of ambiguous lineage: Diagnosis, prognosis and treatment.
Torrent A, Botafogo V, Ribera JM.
Med Clin (Barc). 2025 Jun 27;164(12):106917. doi: 10.1016/j.medcli.2025.106917. Epub 2025 Apr 11.
PMID:40220500
Diagnosis of rare subtypes of acute myeloid leukaemia and related neoplasms.
George TI, Bajel A.
Pathology. 2021 Apr;53(3):312-327. doi: 10.1016/j.pathol.2021.02.001. Epub 2021 Mar 4.
PMID:33676766
Enrichment of Double RUNX1 Mutations in Acute Leukemias of Ambiguous Lineage.
Merati G, Rossi M, Gallì A, Roncoroni E, Zibellini S, Rizzo E, Pietra D, Picone C, Rocca B, Cabrera CPT, Gelli E, Santacroce E, Arcaini L, Zappasodi P.
Front Oncol. 2021 Aug 31;11:726637. doi: 10.3389/fonc.2021.726637. eCollection 2021.
PMID:34540694
Venetoclax in combination with cytarabine with or without idarubicin in children with relapsed or refractory acute myeloid leukaemia: a phase 1, dose-escalation study.
Karol SE, Alexander TB, Budhraja A, Pounds SB, Canavera K, Wang L, Wolf J, Klco JM, Mead PE, Das Gupta S, Kim SY, Salem AH, Palenski T, Lacayo NJ, Pui CH, Opferman JT, Rubnitz JE.
Lancet Oncol. 2020 Apr;21(4):551-560. doi: 10.1016/S1470-2045(20)30060-7. Epub 2020 Mar 11.